| Literature DB >> 30899683 |
Roline Y Barnes1, Jennifer Jelsma2, Romy Parker2,3.
Abstract
BACKGROUND: Musculoskeletal diseases consume a large amount of health and social resources and are a major cause of disability in both low- and high-income countries. In addition, patients frequently present with co-morbid chronic diseases of lifestyle. The area of musculoskeletal disease is restricted by a lack of epidemiological knowledge, particularly in low- and middle-income countries.Entities:
Year: 2019 PMID: 30899683 PMCID: PMC6424002 DOI: 10.4102/ajod.v8i0.428
Source DB: PubMed Journal: Afr J Disabil ISSN: 2223-9170
FIGURE 1Flow chart of recruitment and participation.
Comparison of the demographic characteristics of the two groups (n = 42).
| Variable | Categories | Control ( | Experimental ( | |
|---|---|---|---|---|
| Language | Sesotho | 15 (75) | 11 (50) | 0.285 |
| IsiXhosa | 2 (20) | 6 (27) | ||
| Setswana | 3 (15) | 5 (23) | ||
| Race | African | 20 (100) | 22 (100) | Not applicable |
| Marital status | Married | 7 (35) | 7 (32) | 0.671 |
| Never married | 8 (40) | 7 (32) | ||
| Widowed | 4 (20) | 6 (27) | ||
| Separated or divorced | 0 (0) | 2 (9) | ||
| House ownership | Own | 17 (85) | 18 (81) | 1.000 |
| Friend or family | 3 (15) | 4 (18) | ||
| Type of dwelling | Brick | 15 (75) | 19 (86) | 0.445 |
| Informal | 5 (25) | 3 (14) | ||
| Number of residents per household | 1 | 1 (5) | 2 (9) | 0.866 |
| 2 | 3 (15) | 3 (14) | ||
| 3 | 7 (35) | 5 (23) | ||
| 4 | 2 (10) | 4 (18) | ||
| 5 | 6 (30) | 8 (36) | ||
| 6 | 1 (5) | 0 (0) |
Comparison of the education level and employment status of the two groups (n = 42).
| Variable | Categories | Control ( | Experimental ( | |
|---|---|---|---|---|
| Literacy | Read or write | 20 (100) | 22 (100) | 1.000 |
| Education | Primary | 8 (40) | 8 (36) | 1.000 |
| Secondary | 12 (60) | 14 (64) | ||
| Current employment status | Unemployed | 14 (70) | 19 (8) | 0.003 |
| Pensioner | 6 (30) | 0 (0) | ||
| Worker – part-time | 0 (0) | 3 (14) | ||
| Reason for unemployment ( | Cannot find work | 7 (50) | 10 (53) | 0.971 |
| Health problems | 6 (43) | 8 (42) | ||
| Family care | 1 (7) | 1 (5) | ||
| Receive grant benefits | No | 12 (60) | 16 (73) | 0.515 |
| Yes | 8 (40) | 6 (27) | ||
| Type of grant benefits ( | Disability | 1 (13) | 4 (67) | 0.091 |
| Pension | 7 (88) | 2 (33) |
, values of p < 0.05 are viewed as significant.
FIGURE 2Baseline and 6 weeks frequency of responses to the five dimensions of the EQ-5D-3L for the experimental group.
FIGURE 3Baseline and 6 weeks frequency of responses to the five dimensions of the EQ-5D-3L for the control group.
Between-group comparison of rank ordering of health-related quality of life measures at baseline and at 6 weeks.
| Variable | Experimental ( | Control ( | Adjusted | Effect size Cohen’s | |
|---|---|---|---|---|---|
| Mobility baseline | 1 (1–1) | 1 (1–2) | −1.35 | 0.178 | 0.46 |
| Mobility 6 weeks | 1 (1–1) | 1 (1–1) | −2.13 | 0.034 | 0.75 |
| Self-care baseline | 1 (1–1) | 1 (1–1) | −0.20 | 0.844 | 0.07 |
| Self-care 6 weeks | 1 (1–1) | 1 (1–1) | −1.16 | 0.248 | 0.39 |
| Usual activities baseline | 1 (1–1) | 1 (1–2) | −0.61 | 0.544 | 0.20 |
| Usual activities 6 weeks | 1 (1–1) | 1 (1–1) | −1.16 | 0.248 | 0.39 |
| Pain or discomfort baseline | 2 (1–2) | 2 (1.5–3) | −1.54 | 0.123 | −0.52 |
| Pain or discomfort 6 weeks | 1 (1–2) | 2 (1–2) | −1.77 | 0.077 | −0.61 |
| Anxiety or depression baseline | 2 (1–2) | 2 (1–2.5) | 0.39 | 0.700 | 0.13 |
| Anxiety or depression 6 weeks | 1 (1–1) | 1 (1–1) | −1.37 | 0.171 | 0.46 |
| EQ-5D-3L index score baseline | 0.7 (0.4–0.8) | 0.7 (0.1–0.7) | 0.95 | 0.341 | 0.32 |
| EQ-5D-3L index score 6 weeks | 1.0 (0.8–1.0) | 0.7 (0.7–1.0) | 2.34 | 0.019 | 0.83 |
| VAS baseline | 60 (50–70) | 50 (50–50) | 1.92 | 0.055 | 0.31 |
| VAS 6 weeks | 70 (50–80) | 60 (50–80) | 1.10 | 0.270 | 0.18 |
VAS, Visual Analogue Scale; IQR, interquartile range.
Within-group comparison of measures at baseline and at 6 weeks.
| EQ-5D-3L item | Group | Non-ties | Improvement (%) | Sign test | Effect size Cohen’s |
|---|---|---|---|---|---|
| Mobility | Control | 4 | 100 | 0.5 | |
| Experimental | 9 | 100 | 1.03 | ||
| Self-care | Control | 2 | 50 | 0.24 | |
| Experimental | 3 | 67 | 0 | ||
| Usual activities | Control | 3 | 100 | 0.45 | |
| Experimental | 7 | 100 | 0.84 | ||
| Pain or discomfort | Control | 12 | 75 | 0.49 | |
| Experimental | 24 | 79 | 1.03 | ||
| Anxiety or depression | Control | 9 | 67 | 0.24 | |
| Experimental | 24 | 79 | 1.03 | ||
| EQ-5D-3L index score | Control | 15 | 27 | 0.52 | |
| Experimental | 33 | 21 | 1.23 | ||
| VAS | Control | 13 | 31 | 0.09 | |
| Experimental | 33 | 42 | 0.24 |
VAS, Visual Analogue Scale.
, only the responses of those who completed both assessments are included.
, the sign test calculate the Z statistic calculated based on the non-tied responses, that is, responses which differ from the first to second reading; therefore, the number of non-ties is included.
, a positive Z score indicates improvement and a decrease in the level of problems reported.
, values of p < 0.05 are viewed as significant.
FIGURE 4Boxplots of within-group differences of EQ-5D-3L index scores from baseline to 6 weeks. (a), experimental group, n = 22, and (b) control group, n = 15.
Between-group differences from baseline to 6 weeks in the self-efficacy scale.
| Item | Mean | Standard deviation | Mean | Standard deviation | Effect size Cohen’s | |||
|---|---|---|---|---|---|---|---|---|
| Fatigue | 5.7 | 2.71 | 7.1 | 3.20 | −1.45 | 40 | 0.155 | 0.49 |
| Fatigue | 7.5 | 2.09 | 5.9 | 2.52 | 2.00 | 35 | 0.053 | 0.67 |
| Discomfort | 5.6 | 2.52 | 6.3 | 2.98 | −0.85 | 39 | 0.402 | 0.29 |
| Discomfort | 7.1 | 2.18 | 5.9 | 2.66 | 1.45 | 35 | 0.156 | 0.49 |
| Emotional | 5.9 | 2.65 | 7.0 | 2.82 | −1.23 | 40 | 0.225 | 0.41 |
| Emotional | 7.0 | 2.50 | 5.9 | 2.58 | 1.21 | 35 | 0.236 | 0.41 |
| Symptoms | 5.0 | 3.13 | 6.1 | 2.95 | −1.12 | 40 | 0.271 | 0.35 |
| Symptoms | 6.5 | 2.61 | 6.2 | 2.62 | 0.34 | 35 | 0.734 | 0.11 |
| Tasks | 6.4 | 2.58 | 7.1 | 2.38 | −0.90 | 40 | 0.374 | 0.30 |
| Task | 6.6 | 2.11 | 7.3 | 2.55 | −0.88 | 35 | 0.385 | 0.30 |
| Do things | 5.9 | 2.55 | 7.2 | 2.30 | −1.71 | 40 | 0.095 | 0.57 |
| Do things | 6.09 | 2.71 | 5.8 | 2.83 | 0.31 | 35 | 0.755 | 0.10 |
Within-group differences in self-efficacy items.
| Item | Group | Time | Mean | Standard deviation | Difference (SD) | Effect size | |
|---|---|---|---|---|---|---|---|
| Fatigue | Control | Baseline | 7.0 | 3.3 | −1.1 (3.5) | Baseline: | −0.30 |
| After 6 weeks | 5.9 | 2.5 | |||||
| Experimental | Baseline | 5.7 | 2.7 | 1.7 (3.3) | Baseline: | 0.52 | |
| After 6 weeks | 7.5 | 2.1 | |||||
| Discomfort | Control | Baseline | 6.3 | 3.0 | −0.4 (2.3) | Baseline: | −0.17 |
| After 6 weeks | 5.9 | 2.7 | |||||
| Experimental | Baseline | 5.6 | 2.5 | 1.5 (2.7) | Baseline: | 0.54 | |
| After 6 weeks | 7.0 | 2.2 | |||||
| Emotional | Control | Baseline | 6.7 | 2.9 | −0.8 (2.6) | Baseline: | −0.30 |
| After 6 weeks | 5.9 | 2.6 | |||||
| Experimental | Baseline | 5.9 | 2.7 | 1.0 (3.2) | Baseline: | 0.32 | |
| After 6 weeks | 7.0 | 2.5 | |||||
| Symptoms | Control | Baseline | 6.2 | 2.8 | 0.0 (2.5) | Baseline: | 0.00 |
| After 6 weeks | 6.2 | 2.6 | |||||
| Experimental | Baseline | 5.0 | 3.1 | 1.86 (3.8) | Baseline: | 0.40 | |
| After 6 weeks | 6.5 | 2.6 | |||||
| Tasks | Control | Baseline | 7.1 | 2.5 | 0.1 (3.3) | Baseline: | 0.04 |
| After 6 weeks | 7.3 | 2.5 | |||||
| Experimental | Baseline | 6.4 | 2.6 | 0.2 (2.8) | Baseline: | 0.07 | |
| After 6 weeks | 6.6 | 2.1 | |||||
| Do things | Control | Baseline | 7.3 | 2.3 | −1.5 (3.8) | Baseline: | −0.38 |
| After 6 weeks | 5.8 | 2.8 | |||||
| Experimental | Baseline | 5.9 | 2.6 | 0.2 (3.3) | Baseline: | 0.07 | |
| After 6 weeks | 6.1 | 2.7 |
Experimental group, n = 21, and control group, n =14.
SD, standard deviation.
Between-group comparisons for the 6-min walk test.
| Item | Experimental ( | Control ( | Adjusted | Effect size Cohen’s | |
|---|---|---|---|---|---|
| 6-min walk test – baseline (m) | 552 (500–578) | 445 (420–565) | 2.22 | 0.027 | 0.78 |
| 6 min walk test – 6 weeks | 605 (545–620) | 550 (522–595) | 2.59 | 0.009 | 0.94 |
IQR, interquartile range.
Within-group changes for 6-min walk test.
| Item | Group | Non-ties | Improvement (%) | Effect size Cohen’s | |
|---|---|---|---|---|---|
| 6-min walk test | Control | 15 | 66.7% | 0.102 | |
| Experimental | 22 | 77.3% | 0.866 |